Artemisia annua (Sweet Wormwood).

Artemisinin's endoperoxide bridge is cleaved by ferrous iron and heme, which is what generates its carbon-centred radicals. Iron availability is the switch that turns the molecule from inert to active.

Heme iron cleaves the peroxide bridge more readily than free ferrous iron does. It is the form most often used to demonstrate artemisinin activation in vitro.

Artemisinin's activity depends on the radicals released when its peroxide bridge breaks. A large lipid-phase antioxidant dose quenches those radicals in the same membrane compartment.

Thiols react directly with carbon-centred radicals and raise cellular glutathione, both of which shorten the life of artemisinin's active species. Co-dosing works against what the endoperoxide is there to do.

Artemisinin is cleared largely by CYP2B6 and CYP3A4, and piperine slows several of those hepatic and intestinal enzymes. Plasma levels run higher and last longer as a result.

Artemisinin dissolves poorly in water and depends on micelle formation to cross the gut wall. A lipid carrier raises the fraction that gets absorbed.

Silymarin modulates several CYP enzymes and glucuronidation steps that also handle artemisinin. Co-dosing shifts how quickly the sesquiterpene is cleared.

Artemisinin activity in laboratory models depends on iron-mediated cleavage of its endoperoxide bridge, and ascorbate keeps iron in the reduced ferrous state that drives that cleavage. In cell work the two therefore push the same direction. Ascorbate at high concentration also has its own redox behaviour, so the interaction is not one-way.

Artemisinin works through carbon-centred radicals, and glutathione is the cell's main scavenger of exactly that chemistry. Raising intracellular glutathione is expected to blunt the radical burst rather than add to it. Anyone stacking a strong thiol antioxidant alongside should regard the two as pulling against each other.

Artemisinin is poorly water soluble and its absorption improves in the presence of dietary fat and phospholipid. Lecithin acts as an emulsifier and is the standard way a lipophilic sesquiterpene is dispersed in a capsule. This is formulation chemistry, not a claim about any effect.

Both curcuminoids and artemisinin are poorly soluble lipophiles that share the same absorption problem and the same fat-based solutions. They are frequently co-formulated in the same lipid or phospholipid carrier for that reason. The pairing is a formulation convenience with laboratory work behind each compound separately.

Catechins bind iron avidly, and the iron-dependent step is what activates artemisinin's endoperoxide in laboratory models. A strong polyphenol iron binder taken at the same time can reduce the free iron that chemistry depends on. Direction is predictable from the chemistry; the size of the effect in people has not been measured.

Quercetin both chelates iron and inhibits several cytochrome P450 enzymes, and artemisinin is cleared largely by CYP2B6 and CYP3A4. Those two actions pull in opposite directions on artemisinin exposure. The interaction is real in principle and its net direction in people is unmeasured.

Berberine inhibits CYP3A4 and is a P-glycoprotein substrate, and artemisinin derivatives are cleared through the same CYP3A4 route. Taken together, berberine can slow artemisinin clearance rather than add anything to its own chemistry. Anyone combining herbal bitters with an artemisinin product should expect exposure to shift.

Proanthocyanidins are strong iron binders in the gut lumen, the same property that lowers non-heme iron absorption from a meal. Because artemisinin's laboratory activation is iron-dependent, high-tannin extracts sit on the opposing side. This is inference from established chemistry rather than a tested combination.

Dietary Artemisia annua leaf powder shifted cecal microbial communities in poultry, which is a measurement in birds and not in people. Any co-administered live culture is landing in a gut whose community the plant material is also moving. Direction of the combined effect in humans is unknown.

Carotenoid antioxidants quench the reactive oxygen species that artemisinin's endoperoxide chemistry generates. Stacked at high dose they work against the mechanism laboratory studies attribute to the plant. This is a chemistry-level expectation, untested as a pair.